Document Detail

Stable Delineation of the Ischemic Area by the PET Perfusion Tracer 18F-Fluorobenzyl Triphenyl Phosphonium After Transient Coronary Occlusion.
MedLine Citation:
PMID:  21571789     Owner:  NLM     Status:  Publisher    
(18)F-fluorobenzyl triphenyl phosphonium (FBnTP) has recently been introduced as a myocardial perfusion PET agent. We used a rat model of transient coronary occlusion to determine the stability of the perfusion defect size over time and the magnitude of redistribution. METHODS: Wistar rats (n = 15) underwent thoracotomy and 2-min occlusion of the left coronary artery (LCA), followed by reperfusion. During occlusion, (18)F-FBnTP (92.5 MBq) and (201)Tl-thallium chloride (0.74 MBq) were injected intravenously. One minute before the animals were sacrificed at 5, 45, and 120 min after reperfusion, the LCA was occluded again and 2% Evans blue was injected intravenously to determine the ischemic territory. The hearts were excised, frozen, and sliced for serial dual-tracer autoradiography and histology. Dynamic in vivo (18)F-FBnTP PET was performed on a subgroup of animals (n = 4). RESULTS: (18)F-FBnTP showed stable ischemic defects at all time points after tracer injection and reperfusion. The defects matched the blue dye defect (y = 0.97x+1.5, R(2) = 0.94, y = blue-dye defect, x = (18)F-FBnTP defect). Count density analysis showed no defect fill-in at 45 min but slightly increased activity at 120 min (LCA/remote uptake ratio = 0.19 ± 0.02, 0.19 ± 0.05, and 0.34 ± 0.06 at 5, 45, and 120 min, respectively, P < 0.05). For comparison, (201)Tl showed complete redistribution at 120 min (LCA/remote = 0.42 ± 0.04, 0.72 ± 0.03, and 0.97 ± 0.05 at 5, 45, and 120 min, respectively, P < 0.001). Persistence of the (18)F-FBnTP defect over time was confirmed by in vivo dynamic small-animal PET. CONCLUSION: In a transient coronary occlusion model, perfusion defect size using the new PET agent (18)F-FBnTP remained stable for at least 45 min and matched the histologically defined ischemic area. This lack of significant redistribution suggests a sufficient time window for future clinical protocols with tracer injection remote from the scanner, such as in a stress testing laboratory or chest pain unit.
Takahiro Higuchi; Kenji Fukushima; Christoph Rischpler; Takuro Isoda; Mehrbod S Javadi; Hayden Ravert; Daniel P Holt; Robert F Dannals; Igal Madar; Frank M Bengel
Related Documents :
20801689 - Sudden death due to myocardial metastasis of lingual squamous cell carcinoma.
20129539 - Will imaging assist in the selection of patients with heart failure for an icd?
22266969 - Hypercholesterolemia abrogates sevoflurane-induced delayed preconditioning against myoc...
22913659 - Protective effects of dexrazoxane against acute ischaemia/reperfusion injury of rat hea...
19061709 - Decreased activated protein c levels as a clinical predictor in patients with st-elevat...
3621279 - Differential utility of antiarrhythmic agents.
8944979 - Mechanical circulatory support for post cardiotomy cardiogenic shock in infants.
9550499 - Cholesterol lowering in the management of coronary artery disease: the clinical implica...
13130409 - Association between protease inhibitor use and increased cardiovascular risk in patient...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-5-13
Journal Detail:
Title:  Journal of nuclear medicine : official publication, Society of Nuclear Medicine     Volume:  -     ISSN:  1535-5667     ISO Abbreviation:  -     Publication Date:  2011 May 
Date Detail:
Created Date:  2011-5-16     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0217410     Medline TA:  J Nucl Med     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Division of Nuclear Medicine, Russell H. Morgan Department of Radiology, Johns Hopkins University, Baltimore, Maryland; and.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Use of 18F-FDG PET to predict response to first-line tuberculostatics in HIV-associated tuberculosis...
Next Document:  Developmental Changes in P-Glycoprotein Function in the Blood-Brain Barrier of Nonhuman Primates: PE...